Komori
Annual Securities Report4523Eisai Co.,Ltd.Pharmaceuticals

Annual Securities Report — FY2025

What Eisai Co.,Ltd. reported for the period from 2025-04-01 to 2026-03-31.

How much it says
58Typical
What moved here
26named for the first time
Its own wording
51terms
Which filing this is
37/ 37newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist

Eisai's Annual Securities Report presents consolidated results for FY2025, covering 1 April 2025 to 31 March 2026. Revenue increased, while operating income declined and core operating income increased. The report also describes initiatives based on policies focused on dementia and improving access to medicines, R&D expenses and capital expenditures, and the issuance of unsecured bonds as a subsequent event.

Komori's summary of this document, not the document's own words.
58Typical
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 37 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
76
Very detailed
Magnitude of change
68
Detailed
Strategic shift
100
Very detailed
Capital movements
62
Detailed
Disclosure Gaps
0
Almost nothing
Concentration Risk
100
Very detailed
Future commitments
0
Almost nothing
Change in Risk
55
Typical
Financial and Capital Policy
60
Detailed
Product Portfolio
55
Typical
Technology Position
50
Typical
Confidence in Strategic Bets
R&D spend1,587億円Money spent making new things.
Cash left over195億円Cash from the business, less what went into equipment.
Spent on equipment207億円Plants, machines — things meant to last.
Employees2,979Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.
Eisai Co.,Ltd. — FY2025 | Komori